Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes.

Block of the delayed rectifier potassium current, IK, by the class IC antiarrhythmic agent, flecainide, and by the novel selective class III antiarrhythmic agent, E-4031, were compared in isolated cat ventricular myocytes using the single suction-pipette, voltage-clamp technique. Flecainide (10 microM) markedly reduced IK elicited on depolarization steps to plateau voltages (+10 mV) and nearly completely blocked the "tail currents" elicited on repolarization to -40 mV (93 +/- 4% block at +40 mV, n = 3). E-4031 (1 microM) produced similar effects (96 +/- 3% block at +40 mV, n = 3). Slow voltage ramps from -100 to +40 mV confirmed inward rectifying properties of IK and showed that flecainide and E-4031 have no effects on the background potassium current, IK1. Thus, the results demonstrate that block of IK is a common feature of flecainide and E-4031. IK block by E-4031 most likely underlies the drug's potent class III antiarrhythmic properties. On the other hand, flecainide block of IK during an action potential would tend to prolong repolarization, but this effect may be obscured by concomitant block of plateau Na+ channels to produce little or no change in action potential duration, consistent with its class IC classification.

[1]  S. Olsson,et al.  Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation. , 1981, American heart journal.

[2]  B. Surawicz,et al.  Effect of Altered Repolarization Course Induced by Antiarrhythmic Drugs and Constant Current Pulses on Duration of Premature Action Potentials in Canine Cardiac Purkinje Fibers , 1989, Journal of cardiovascular pharmacology.

[3]  B. Lucchesi,et al.  Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models. , 1985, European journal of pharmacology.

[4]  G. Vassort,et al.  Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. , 1989, The American journal of physiology.

[5]  D C Harrison,et al.  Antiarrhythmic drug classification: new science and practical applications. , 1985, The American journal of cardiology.

[6]  D. Noble,et al.  Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres , 1969, The Journal of physiology.

[7]  T. Shibasaki,et al.  Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart. , 1987, The Journal of physiology.

[8]  J. Rozanski,et al.  Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction. , 1989, American heart journal.

[9]  P. Coumel,et al.  [Flecainide: a new antiarrhythmic agent]. , 1983, Archives des maladies du coeur et des vaisseaux.

[10]  S. Houser,et al.  Isolation and morphology of calcium-tolerant feline ventricular myocytes. , 1983, The American journal of physiology.

[11]  R. Kass,et al.  Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. , 1988, Molecular pharmacology.

[12]  D. Clapham,et al.  Delayed rectifier K+ current in embryonic chick heart ventricle. , 1988, The American journal of physiology.

[13]  A Shrier,et al.  Repolarization currents in embryonic chick atrial heart cell aggregates. , 1986, Biophysical journal.

[14]  E. Carmeliet Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. , 1985, The Journal of pharmacology and experimental therapeutics.

[15]  T. Colatsky Mechanisms of Action of Lidocaine and Quinidine on Action Potential Duration in Rabbit Cardiac Purkinje Fibers: An Effect on Steady State Sodium Currents? , 1982, Circulation research.

[16]  U. Borchard,et al.  Effect of Flecainide on Action Potentials and Alternating Current‐Induced Arrhythmias in Mammalian Myocardium , 1982, Journal of cardiovascular pharmacology.

[17]  T. Colatsky,et al.  K+ Channel Blockers and Activators in Cardiac Arrhythmias , 1989 .

[18]  D. Tepper,et al.  Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. , 1987, American heart journal.

[19]  G. J. Conard,et al.  Metabolism of flecainide. , 1984, The American journal of cardiology.

[20]  B. Lucchesi,et al.  Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. , 1984, Journal of cardiovascular pharmacology.

[21]  L. D. Davis,et al.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. , 1985, Journal of the American College of Cardiology.

[22]  E. Williams Electrophysiological basis for a rational approach to antidysrhythmic drug therapy. , 1974, Advances in drug research.